| Year |
Citation |
Score |
| 2023 |
Tandon R, Nasrallah H, Akbarian S, Carpenter WT, DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, Malaspina D, Meyer-Lindenberg A, Murray R, Owen M, Smoller JW, et al. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. Schizophrenia Research. 264: 1-28. PMID 38086109 DOI: 10.1016/j.schres.2023.11.015 |
0.307 |
|
| 2023 |
Misiak B, Samochowiec J, Kowalski K, Gaebel W, Bassetti CLA, Chan A, Gorwood P, Papiol S, Dom G, Volpe U, Szulc A, Kurimay T, Kärkkäinen H, Decraene A, Wisse J, et al. The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia. European Psychiatry : the Journal of the Association of European Psychiatrists. 66: e58. PMID 37476977 DOI: 10.1192/j.eurpsy.2023.2432 |
0.302 |
|
| 2022 |
Gaebel W, Salveridou-Hof E. Reinventing schizophrenia: Updating the construct - Primary schizophrenia 2021 - The road ahead. Schizophrenia Research. PMID 35033393 DOI: 10.1016/j.schres.2021.12.021 |
0.311 |
|
| 2020 |
Hasan A, Falkai P, Lehmann I, Gaebel W. Schizophrenia. Deutsches Arzteblatt International. 117: 412-419. PMID 32865492 DOI: 10.3238/Arztebl.2020.0412 |
0.412 |
|
| 2020 |
Gaebel W, Kerst A, Janssen B, Becker T, Musalek M, Rössler W, Ruggeri M, Thornicroft G, Zielasek J, Stricker J. EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination. European Psychiatry. 63: 1-47. PMID 32703326 DOI: 10.1192/J.Eurpsy.2020.75 |
0.321 |
|
| 2020 |
Gaebel W, Stricker J, Kerst A. Changes from ICD-10 to ICD-11 and future directions in psychiatric classification
. Dialogues in Clinical Neuroscience. 22: 7-15. PMID 32699501 DOI: 10.31887/Dcns.2020.22.1/Wgaebel |
0.318 |
|
| 2020 |
Gaebel W, Stricker J. Qualitätsgesicherte Psychiatrie und Entstigmatisierung: Kann qualitätsgesicherte Psychiatrie und Psychotherapie zur Entstigmatisierung psychischer Erkrankungen beitragen? Nervenarzt. 91: 792-798. PMID 32607603 DOI: 10.1007/S00115-020-00941-W |
0.357 |
|
| 2020 |
Montag C, Brandt L, Lehmann A, de Millas W, Falkai P, Gaebel W, Hasan A, Hellmich M, Janssen B, Juckel G, Karow A, Klosterkötter J, Lambert M, Maier W, Müller H, et al. Cognitive and Emotional Empathy in Individuals at Clinical High Risk of Psychosis. Acta Psychiatrica Scandinavica. PMID 32339254 DOI: 10.1111/Acps.13178 |
0.304 |
|
| 2020 |
Stein DJ, Szatmari P, Gaebel W, Berk M, Vieta E, Maj M, de Vries YA, Roest AM, de Jonge P, Maercker A, Brewin CR, Pike KM, Grilo CM, Fineberg NA, Briken P, et al. Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies. Bmc Medicine. 18: 21. PMID 31983345 DOI: 10.1186/S12916-020-1495-2 |
0.34 |
|
| 2020 |
Gaebel W, Falkai P, Hasan A. The revised German evidence- and consensus-based schizophrenia guideline. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 19: 117-119. PMID 31922675 DOI: 10.1002/Wps.20706 |
0.38 |
|
| 2019 |
Gaebel W, Stricker J, Riesbeck M. The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples. Schizophrenia Research. PMID 31806527 DOI: 10.1016/J.Schres.2019.10.049 |
0.37 |
|
| 2019 |
Gaebel W, Stricker J, Riesbeck M, Zielasek J, Kerst A, Meisenzahl-Lechner E, Köllner V, Rose M, Hofmann T, Schäfer I, Lotzin A, Briken P, Klein V, Brunner F, Keeley JW, et al. Accuracy of diagnostic classification and clinical utility assessment of ICD-11 compared to ICD-10 in 10 mental disorders: findings from a web-based field study. European Archives of Psychiatry and Clinical Neuroscience. PMID 31654119 DOI: 10.1007/S00406-019-01076-Z |
0.309 |
|
| 2019 |
Hasan A, Falkai P, Lehmann I, Janssen B, Wobrock T, Zielasek J, Gaebel W. [Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations]. Der Nervenarzt. PMID 31605161 DOI: 10.1007/S00115-019-00813-Y |
0.44 |
|
| 2019 |
Gaebel W, Zäske H, Hesse K, Klingberg S, Ohmann C, Grebe J, Kolbe H, Icks A, Schneider F, Backes V, Wolff-Menzler C, Guse B, Gallinat J, Bock T, Jockers-Scherübl MC, et al. Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT. European Archives of Psychiatry and Clinical Neuroscience. PMID 31520149 DOI: 10.1007/S00406-019-01064-3 |
0.406 |
|
| 2019 |
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, et al. A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. European Archives of Psychiatry and Clinical Neuroscience. PMID 31486890 DOI: 10.1007/S00406-019-01063-4 |
0.369 |
|
| 2019 |
Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial. European Archives of Psychiatry and Clinical Neuroscience. PMID 31463563 DOI: 10.1007/S00406-019-01055-4 |
0.411 |
|
| 2019 |
Schennach R, Obermeier M, Spellmann I, Seemüller F, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, et al. Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression. Schizophrenia Research. PMID 31138482 DOI: 10.1016/J.Schres.2019.04.022 |
0.414 |
|
| 2019 |
Peterson DL, Webb CA, Keeley JW, Gaebel W, Zielasek J, Rebello TJ, Robles R, Matsumoto C, Kogan CS, Kulygina M, Farooq S, Green MF, Falkai P, Hasan A, Galderisi S, et al. The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial. Schizophrenia Research. PMID 30799218 DOI: 10.1016/J.Schres.2019.02.011 |
0.358 |
|
| 2019 |
Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, et al. Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine. Schizophrenia Research. PMID 30704862 DOI: 10.1016/J.Schres.2019.01.021 |
0.363 |
|
| 2019 |
Kleineidam L, Frommann I, Ruhrmann S, Klosterkötter J, Brockhaus-Dumke A, Wölwer W, Gaebel W, Maier W, Wagner M, Ettinger U. Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion. European Archives of Psychiatry and Clinical Neuroscience. PMID 30635714 DOI: 10.1007/S00406-018-0973-4 |
0.383 |
|
| 2019 |
Kerst A, Zielasek J, Gaebel W. Smartphone applications for depression: a systematic literature review and a survey of health care professionals' attitudes towards their use in clinical practice. European Archives of Psychiatry and Clinical Neuroscience. PMID 30607530 DOI: 10.1007/S00406-018-0974-3 |
0.325 |
|
| 2019 |
Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, Maj M, Stein DJ, Maercker A, Tyrer P, Claudino A, Garralda E, Salvador-Carulla L, Ray R, Saunders JB, et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 3-19. PMID 30600616 DOI: 10.1002/Wps.20611 |
0.344 |
|
| 2018 |
Kamp D, Engelke C, Wobrock T, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, et al. Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial. Schizophrenia Research. PMID 30249471 DOI: 10.1016/J.Schres.2018.09.017 |
0.383 |
|
| 2018 |
Gaebel W, Kerst A. The debate about renaming schizophrenia: a new name would not resolve the stigma. Epidemiology and Psychiatric Sciences. 28: 258-261. PMID 30203732 DOI: 10.1017/S2045796018000513 |
0.42 |
|
| 2018 |
Reed GM, Keeley JW, Rebello TJ, First MB, Gureje O, Ayuso-Mateos JL, Kanba S, Khoury B, Kogan CS, Krasnov VN, Maj M, de Jesus Mari J, Sharan P, Stein DJ, Zhao M, ... ... Gaebel W, et al. Clinical utility of ICD-11 diagnostic guidelines for high-burden mental disorders: results from mental health settings in 13 countries. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 306-315. PMID 30192090 DOI: 10.1002/Wps.20581 |
0.367 |
|
| 2018 |
Winkler P, Broulíková HM, Kondrátová L, Knapp M, Arteel P, Boyer P, Galderisi S, Karkkainen H, Ieven A, Mohr P, Wasserman D, Park AL, Tinelli M, Gaebel W. Value of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech Republic. European Psychiatry : the Journal of the Association of European Psychiatrists. 53: 116-122. PMID 30036774 DOI: 10.1016/J.Eurpsy.2018.06.008 |
0.301 |
|
| 2018 |
Mohr P, Galderisi S, Boyer P, Wasserman D, Arteel P, Ieven A, Karkkainen H, Pereira E, Guldemond N, Winkler P, Gaebel W. Value of schizophrenia treatment I: The patient journey. European Psychiatry : the Journal of the Association of European Psychiatrists. 53: 107-115. PMID 30036773 DOI: 10.1016/J.Eurpsy.2018.06.007 |
0.398 |
|
| 2018 |
Keeley JW, Gaebel W, First MB, Peterson DL, Rebello T, Sharan P, Reed GM. Psychotic disorder symptom rating scales: Are dichotomous or multi-point scales more clinically useful?-An ICD-11 field study. Schizophrenia Research. PMID 30017460 DOI: 10.1016/J.Schres.2018.07.006 |
0.304 |
|
| 2018 |
Reed GM, Sharan P, Rebello TJ, Keeley JW, Elena Medina-Mora M, Gureje O, Luis Ayuso-Mateos J, Kanba S, Khoury B, Kogan CS, Krasnov VN, Maj M, de Jesus Mari J, Stein DJ, Zhao M, ... ... Gaebel W, et al. The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders: results among adult patients in mental health settings of 13 countries. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 174-186. PMID 29856568 DOI: 10.1002/Wps.20524 |
0.363 |
|
| 2018 |
Zäske H, Linden M, Degner D, Jockers-Scherübl M, Klingberg S, Klosterkötter J, Maier W, Möller HJ, Sauer H, Schmitt A, Gaebel W. Stigma experiences and perceived stigma in patients with first-episode schizophrenia in the course of 1 year after their first in-patient treatment. European Archives of Psychiatry and Clinical Neuroscience. PMID 29696357 DOI: 10.1007/S00406-018-0892-4 |
0.399 |
|
| 2018 |
Zielasek J, Gaebel W. [Schizophrenia and other primary psychotic disorders in ICD-11]. Fortschritte Der Neurologie-Psychiatrie. 86: 178-183. PMID 29621821 DOI: 10.1055/S-0044-101832 |
0.412 |
|
| 2018 |
Hansbauer M, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, et al. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis. Psychiatry Research. 263: 22-29. PMID 29482042 DOI: 10.1093/Schbul/Sby018.836 |
0.366 |
|
| 2017 |
Wessels H, Wagner M, Kuhr K, Berning J, Pützfeld V, Janssen B, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, Maier W, Klosterkötter J, Bechdolf A. Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis. Early Intervention in Psychiatry. PMID 28675695 DOI: 10.1111/Eip.12460 |
0.345 |
|
| 2017 |
Keeley JW, Gaebel W. Symptom rating scales for schizophrenia and other primary psychotic disorders in ICD-11. Epidemiology and Psychiatric Sciences. 27: 219-224. PMID 28625216 DOI: 10.1017/S2045796017000270 |
0.34 |
|
| 2017 |
Gaebel W, Zielasek J, Reed GM. Mental and behavioural disorders in the ICD-11: concepts, methodologies, and current status. Psychiatria Polska. 51: 169-195. PMID 28581530 DOI: 10.12740/Pp/69660 |
0.351 |
|
| 2017 |
Kamp D, Engelke C, Wobrock T, Kunze B, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, et al. Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia. Schizophrenia Research. PMID 28578924 DOI: 10.1016/J.Schres.2017.05.036 |
0.334 |
|
| 2017 |
Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How? Pharmacopsychiatry. PMID 28505669 DOI: 10.1055/S-0043-106436 |
0.407 |
|
| 2017 |
Großimlinghaus I, Hauth I, Falkai P, Janssen B, Deister A, Meyer-Lindenberg A, Roth-Sackenheim C, Schneider F, Wobrock T, Zeidler R, Gaebel W. [DGPPN recommendations on quality indicators for schizophrenia]. Der Nervenarzt. PMID 28484822 DOI: 10.1007/S00115-017-0347-6 |
0.34 |
|
| 2017 |
Gaebel W. E-Mental Health for Mental Disorders–Focus on Psychotic Disorders and PTSD European Psychiatry. 41: S42-S42. DOI: 10.1016/J.Eurpsy.2017.01.189 |
0.327 |
|
| 2017 |
Gaebel W. ICD-11: Example of Psychotic Disorders European Psychiatry. 41: S31-S31. DOI: 10.1016/J.Eurpsy.2017.01.150 |
0.383 |
|
| 2017 |
Gaebel W. How Can Guidance Recommendations Contribute to Better Mental Health? European Psychiatry. 41: S12-S12. DOI: 10.1016/J.Eurpsy.2017.01.089 |
0.306 |
|
| 2017 |
Gaebel W. Closing the Treatment Gap: The EPA Case Study of Schizophrenia European Psychiatry. 41: S4-S4. DOI: 10.1016/J.Eurpsy.2017.01.019 |
0.411 |
|
| 2016 |
Spellmann I, Schennach R, Seemüller F, Meyer S, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, et al. Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies. European Archives of Psychiatry and Clinical Neuroscience. PMID 27785605 DOI: 10.1007/S00406-016-0741-2 |
0.425 |
|
| 2016 |
Baethge C, Jänner M, Gaebel W, Malevani J. Psychopathological and demographic characteristics of hallucinating patients with schizophrenia and schizoaffective disorder: an analysis based on AMDP data. European Archives of Psychiatry and Clinical Neuroscience. PMID 27752826 DOI: 10.1007/S00406-016-0738-X |
0.427 |
|
| 2016 |
Cordes J, Bechdolf A, Engelke C, Kahl KG, Balijepalli C, Lösch C, Klosterkötter J, Wagner M, Maier W, Heinz A, de Millas W, Gaebel W, Winterer G, Janssen B, Schmidt-Kraepelin C, et al. Prevalence of metabolic syndrome in female and male patients at risk of psychosis. Schizophrenia Research. PMID 27751654 DOI: 10.1016/J.Schres.2016.09.012 |
0.336 |
|
| 2016 |
Hasan A, Wobrock T, Guse B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Musso F, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, et al. Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia. Molecular Psychiatry. PMID 27725655 DOI: 10.1038/Mp.2016.161 |
0.381 |
|
| 2016 |
Rausch F, Eisenacher S, Elkin H, Englisch S, Kayser S, Striepens N, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, et al. Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria. Psychological Medicine. 1-11. PMID 27094404 DOI: 10.1017/S0033291716000465 |
0.307 |
|
| 2016 |
Gaebel W, Großimlinghaus I, Kerst A, Cohen Y, Hinsche-Böckenholt A, Johnson B, Mucic D, Petrea I, Rössler W, Thornicroft G, Zielasek J. European Psychiatric Association (EPA) guidance on the quality of eMental health interventions in the treatment of psychotic disorders. European Archives of Psychiatry and Clinical Neuroscience. PMID 26874958 DOI: 10.1007/S00406-016-0677-6 |
0.32 |
|
| 2016 |
Keeley JW, Reed GM, Roberts MC, Evans SC, Medina-Mora ME, Robles R, Rebello T, Sharan P, Gureje O, First MB, Andrews HF, Ayuso-Mateos JL, Gaebel W, Zielasek J, Saxena S. Developing a science of clinical utility in diagnostic classification systems field study strategies for ICD-11 mental and behavioral disorders. The American Psychologist. 71: 3-16. PMID 26766762 DOI: 10.1037/A0039972 |
0.332 |
|
| 2016 |
Gaebel W. Promoting stigma coping and empowerment: Results from the multi-center clinical trial STEM European Psychiatry. 33: S40-S40. DOI: 10.1016/J.Eurpsy.2016.01.885 |
0.354 |
|
| 2016 |
Kowitz S, Zielasek J, Gaebel W. Patients with anxiety disorders: Pathways of care and their outcomes in Germany – A secondary data analysis European Psychiatry. 33: S193-S193. DOI: 10.1016/J.Eurpsy.2016.01.440 |
0.328 |
|
| 2016 |
Möller-Leimkühler AM, Möller HJ, Maier W, Gaebel W, Falkai P. EPA guidance on improving the image of psychiatry European Archives of Psychiatry and Clinical Neuroscience. 266: 139-154. DOI: 10.1007/S00406-016-0678-5 |
0.305 |
|
| 2016 |
Gaebel W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller HJ, Wölwer W. Concept and results of the German Research Network on Schizophrenia | Konzept und Ergebnisse des Kompetenznetzes Schizophrenie Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 59: 412-419. DOI: 10.1007/S00103-016-2311-1 |
0.382 |
|
| 2015 |
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, de Millas W, Maier W, Ruhrmann S, Falkai P, Sauer H, Schmitt A, Riedel M, Klingberg S, Möller HJ. Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia. Schizophrenia Research. PMID 26607102 DOI: 10.1016/J.Schres.2015.10.024 |
0.396 |
|
| 2015 |
Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch MA, Maske U, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. [Erratum to: Mental disorders in the general population. Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Der Nervenarzt. PMID 26601984 DOI: 10.1007/S00115-015-4458-7 |
0.334 |
|
| 2015 |
Hasan A, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, et al. Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial. Schizophrenia Bulletin. PMID 26433217 DOI: 10.1093/Schbul/Sbv142 |
0.366 |
|
| 2015 |
Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch MA, Hapke U, Maske U, Seiffert I, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. Twelve-months prevalence of mental disorders in the German Health Interview and Examination Survey for Adults - Mental Health Module (DEGS1-MH): a methodological addendum and correction. International Journal of Methods in Psychiatric Research. PMID 26184561 DOI: 10.1002/Mpr.1479 |
0.311 |
|
| 2015 |
Schennach R, Möller HJ, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods. International Journal of Methods in Psychiatric Research. PMID 26178421 DOI: 10.1002/Mpr.1476 |
0.385 |
|
| 2015 |
Mack S, Jacobi F, Beesdo-Baum K, Gerschler A, Strehle J, Höfler M, Busch MA, Maske U, Hapke U, Gaebel W, Zielasek J, Maier W, Wittchen HU. Functional disability and quality of life decrements in mental disorders: Results from the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). European Psychiatry : the Journal of the Association of European Psychiatrists. PMID 26169476 DOI: 10.1016/J.Eurpsy.2015.06.003 |
0.304 |
|
| 2015 |
Großimlinghaus I, Falkai P, Gaebel W, Hasan A, Jänner M, Janssen B, Reich-Erkelenz D, Grüber L, Böttcher V, Wobrock T, Zielasek J. [Assessment of quality indicators with routine data: Presentation of a feasibility test in ten specialist clinics for psychiatry and psychotherapy]. Der Nervenarzt. 86: 1393-9. PMID 26122639 DOI: 10.1007/S00115-015-4357-Y |
0.325 |
|
| 2015 |
Gaebel W, Zielasek J. Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry and Clinical Neurosciences. 69: 661-73. PMID 26011091 DOI: 10.1111/pcn.12322 |
0.317 |
|
| 2015 |
Rietschel L, Lambert M, Karow A, Zink M, Müller H, Heinz A, de Millas W, Janssen B, Gaebel W, Schneider F, Naber D, Juckel G, Krüger-Özgürdal S, Wobrock T, Wagner M, et al. Clinical high risk for psychosis: gender differences in symptoms and social functioning. Early Intervention in Psychiatry. PMID 25808791 DOI: 10.1111/Eip.12240 |
0.329 |
|
| 2015 |
Wobrock T, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, et al. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biological Psychiatry. 77: 979-88. PMID 25582269 DOI: 10.1016/J.Biopsych.2014.10.009 |
0.373 |
|
| 2015 |
Schennach R, Riedel M, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder? European Psychiatry : the Journal of the Association of European Psychiatrists. 30: 43-50. PMID 25541347 DOI: 10.1016/J.Eurpsy.2014.11.001 |
0.388 |
|
| 2015 |
Schennach R, Riedel M, Obermeier M, Spellmann I, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, et al. What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial. European Archives of Psychiatry and Clinical Neuroscience. 265: 107-16. PMID 25261210 DOI: 10.1007/S00406-014-0528-2 |
0.367 |
|
| 2015 |
Kowitz S, Zielasek J, Gaebel W. Use of Mental Health Care Services by People with Depression in Germany: a Secondary Data Analysis European Psychiatry. 30: 1850. DOI: 10.1016/S0924-9338(15)32119-2 |
0.315 |
|
| 2015 |
Gaebel W. The EPa Guidance Project European Psychiatry. 30: 31. DOI: 10.1016/S0924-9338(15)31825-3 |
0.301 |
|
| 2015 |
Großimlinghaus I, Gaebel W, Janssen B, Zielasek J. Quality Assurance in German Mental Healthcare European Psychiatry. 30: 1910. DOI: 10.1016/S0924-9338(15)31461-9 |
0.301 |
|
| 2015 |
Zäske H, Gaebel W. Stigma and Discrimination Experiences in Patients with First-episode Schizophrenia European Psychiatry. 30: 1377. DOI: 10.1016/S0924-9338(15)31068-3 |
0.38 |
|
| 2015 |
Schmidt-Kraepelin C, Zielasek J, Jänner M, Wittchen H, Jacobi F, Höfler M, Siegert J, Mack S, Gerschler A, Scholl L, Busch M, Hapke U, Maske U, Gaebel W. Psychotic-like Experiences: Preliminary Results From the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH) European Psychiatry. 30: 818. DOI: 10.1016/S0924-9338(15)30639-8 |
0.331 |
|
| 2015 |
Ruttmann A, Schmidt-Kraepelin C, Zielasek J, Menge T, Seitz R, FRCP HH, Gaebel W. Assessing the Intensity and Frequency of Symptoms of Mental Disorders in Patients with Neurological Disorders European Psychiatry. 30: 415. DOI: 10.1016/S0924-9338(15)30330-8 |
0.554 |
|
| 2015 |
Gaebel W. European Psychiatry: Practice, Education, and Research European Psychiatry. 30: 6. DOI: 10.1016/S0924-9338(15)30004-3 |
0.328 |
|
| 2015 |
Bhugra D, Sartorius N, Fiorillo A, Evans-Lacko S, Ventriglio A, Hermans MHM, Vallon P, Dales J, Racetovic G, Samochowiec J, Roca Bennemar M, Becker T, Kurimay T, Gaebel W. EPA guidance on how to improve the image of psychiatry and of the psychiatrist European Psychiatry. 30: 423-430. DOI: 10.1016/J.Eurpsy.2015.02.003 |
0.33 |
|
| 2015 |
Bhugra D, Ventriglio A, Kuzman MR, Ikkos G, Hermans MHM, Falkai P, Fiorillo A, Musalek M, Hoschl C, Dales J, Beezhold J, Rössler W, Racetovic G, Gaebel W. EPA guidance on the role and responsibilities of psychiatrists European Psychiatry. 30: 417-422. DOI: 10.1016/J.Eurpsy.2015.02.002 |
0.33 |
|
| 2015 |
Zäske H, Degner D, Jockers-Scherübl M, Klingberg S, Klosterkötter J, Maier W, Möller HJ, Sauer H, Schmitt A, Gaebel W. Experiences of stigma and discrimination in patients with first-episode schizophrenia | Erleben von Stigma und Diskriminierung bei ersterkrankten Schizophreniepatienten Nervenarzt. DOI: 10.1007/S00115-015-4340-7 |
0.369 |
|
| 2014 |
Luckhaus C, Kampka N, Frommann N, Dönisch-Seidel U, Gaebel W, Janssen B. Pilot study on a modular outpatient treatment programme following public order placements because of endangerment in patients with psychotic disorders | Pilot-anwendung eines modularen ambulanten therapieprogramms im anschluss an PsychKG-unterbringungen wegen fremdgefährdung bei patienten mit psychose-erkrankungen Fortschritte Der Neurologie Psychiatrie. 82: 464-470. PMID 25105433 DOI: 10.1055/S-0034-1366586 |
0.318 |
|
| 2014 |
Kowitz S, Zielasek J, Gaebel W. Mental healthcare in Germany - Current situation and perspectives | Die Versorgungssituation bei psychischen Störungen in Deutschland: Aktueller Stand und Perspektiven Deutsche Medizinische Wochenschrift. 139: 1249-1252. PMID 24866962 DOI: 10.1055/S-0034-1370039 |
0.318 |
|
| 2014 |
Wölwer W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, Mobascher A, Gaebel W, Cordes J. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimulation. 7: 559-63. PMID 24857264 DOI: 10.1016/J.Brs.2014.04.011 |
0.381 |
|
| 2014 |
Jacobi F, Höfler M, Siegert J, Mack S, Gerschler A, Scholl L, Busch MA, Hapke U, Maske U, Seiffert I, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). International Journal of Methods in Psychiatric Research. 23: 304-19. PMID 24729411 DOI: 10.1002/Mpr.1439 |
0.333 |
|
| 2014 |
Gaebel W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Wölwer W. 12 years of competence network schizophrenia: Results and perspectives | 12 Jahre Kompetenznetz Schizophrenie: Ergebnisse und Perspektiven Fortschritte Der Neurologie Psychiatrie. 82: 191-202. PMID 24710675 DOI: 10.1055/S-0034-1366193 |
0.334 |
|
| 2014 |
Mack S, Jacobi F, Gerschler A, Strehle J, Höfler M, Busch MA, Maske UE, Hapke U, Seiffert I, Gaebel W, Zielasek J, Maier W, Wittchen HU. Self-reported utilization of mental health services in the adult German population--evidence for unmet needs? Results of the DEGS1-Mental Health Module (DEGS1-MH). International Journal of Methods in Psychiatric Research. 23: 289-303. PMID 24687693 DOI: 10.1002/Mpr.1438 |
0.328 |
|
| 2014 |
Kommescher M, Wagner M, Pützfeld V, Berning J, Janssen B, Decker P, Bottlender R, Möller HJ, Gaebel W, Maier W, Klosterkötter J, Bechdolf A. Coping as a predictor of treatment outcome in people at clinical high risk of psychosis. Early Intervention in Psychiatry. PMID 24612629 DOI: 10.1111/Eip.12130 |
0.343 |
|
| 2014 |
Seemüller F, Meier S, Obermeier M, Musil R, Bauer M, Adli M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Riedel M, et al. Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. European Archives of Psychiatry and Clinical Neuroscience. 264: 567-75. PMID 24590257 DOI: 10.1007/S00406-014-0495-7 |
0.338 |
|
| 2014 |
Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, et al. Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function. Acta Psychiatrica Scandinavica. 130: 214-26. PMID 24571191 DOI: 10.1111/Acps.12258 |
0.383 |
|
| 2014 |
Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch MA, Maske U, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. [Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Der Nervenarzt. 85: 77-87. PMID 24441882 DOI: 10.1007/S00115-013-3961-Y |
0.304 |
|
| 2014 |
Malaspina D, Walsh-Messinger J, Gaebel W, Smith LM, Gorun A, Prudent V, Antonius D, Trémeau F. Negative symptoms, past and present: a historical perspective and moving to DSM-5. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 710-24. PMID 24314851 DOI: 10.1016/J.Euroneuro.2013.10.018 |
0.338 |
|
| 2014 |
Maruta T, Volpe U, Gaebel W, Matsumoto C, Iimori M. Should schizophrenia still be named so? Schizophrenia Research. 152: 305-6. PMID 24275581 DOI: 10.1016/J.Schres.2013.11.005 |
0.373 |
|
| 2014 |
Gaebel W, Riesbeck M. Are there clinically useful predictors and early warning signs for pending relapse? Schizophrenia Research. 152: 469-77. PMID 23978776 DOI: 10.1016/J.Schres.2013.08.003 |
0.374 |
|
| 2014 |
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Heuser I, Maier W, Klosterkötter J, Falkai P, Schlösser R, Schmitt A, Riedel M, Klingberg S, Köpcke W, et al. Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia. Schizophrenia Research. 152: 478-86. PMID 23643327 DOI: 10.1016/J.Schres.2013.04.012 |
0.411 |
|
| 2014 |
Gaebel W. EPA-1463 – EPA guidance and the Future of European Psychiatry European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78656-0 |
0.318 |
|
| 2014 |
Gaebel W. EPA-1462 – ICD-11: update and field trials on psychotic disorders European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78655-9 |
0.393 |
|
| 2014 |
Wobrock T, Hasan A, Falkai P, Cordes J, Gaebel W, Langguth B, Landgrebe M. EPA-1454 - TMS and negative symptoms European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78647-X |
0.37 |
|
| 2014 |
Gaebel W. ARE THERE CLINICALLY USEFUL PREDICTORS AND EARLY WARNING SIGNS FOR RELAPSE IN SCHIZOPHRENIA? Schizophrenia Research. 153: S36-S37. DOI: 10.1016/S0920-9964(14)70121-5 |
0.373 |
|
| 2013 |
Hasan A, Wobrock T, Gaebel W, Janssen B, Zielasek J, Falkai P. National and international schizophrenia guidelines: Update 2013 regarding recommendations about antipsychotic pharmacotherapy | Nationale und internationale Leitlinien zur Schizophrenie: Update 2013 zum Stand der Empfehlungen zur antipsychotischen Medikation Nervenarzt. 84: 1359-1368. PMID 24077969 DOI: 10.1007/S00115-013-3913-6 |
0.379 |
|
| 2013 |
Tandon R, Heckers S, Bustillo J, Barch DM, Gaebel W, Gur RE, Malaspina D, Owen MJ, Schultz S, Tsuang M, van Os J, Carpenter W. Catatonia in DSM-5. Schizophrenia Research. 150: 26-30. PMID 23806583 DOI: 10.1016/J.Schres.2013.04.034 |
0.388 |
|
| 2013 |
Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Tsuang M, Van Os J, Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophrenia Research. 150: 3-10. PMID 23800613 DOI: 10.1016/J.Schres.2013.05.028 |
0.42 |
|
| 2013 |
Jacobi F, Mack S, Gerschler A, Scholl L, Höfler M, Siegert J, Bürkner A, Preiss S, Spitzer K, Busch M, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, et al. The design and methods of the mental health module in the German Health Interview and Examination Survey for Adults (DEGS1-MH). International Journal of Methods in Psychiatric Research. 22: 83-99. PMID 23788523 DOI: 10.1002/Mpr.1387 |
0.329 |
|
| 2013 |
Tsuang MT, Van Os J, Tandon R, Barch DM, Bustillo J, Gaebel W, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Carpenter W. Attenuated psychosis syndrome in DSM-5. Schizophrenia Research. 150: 31-5. PMID 23773295 DOI: 10.1016/J.Schres.2013.05.004 |
0.396 |
|
| 2013 |
Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, Barch DM, Gaebel W, Gur RE, Tsuang M, Van Os J, Carpenter W. Schizoaffective Disorder in the DSM-5. Schizophrenia Research. 150: 21-5. PMID 23707642 DOI: 10.1016/J.Schres.2013.04.026 |
0.389 |
|
| 2013 |
Heckers S, Barch DM, Bustillo J, Gaebel W, Gur R, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W. Structure of the psychotic disorders classification in DSM-5. Schizophrenia Research. 150: 11-4. PMID 23707641 DOI: 10.1016/J.Schres.2013.04.039 |
0.407 |
|
| 2013 |
Barch DM, Bustillo J, Gaebel W, Gur R, Heckers S, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophrenia Research. 150: 15-20. PMID 23706415 DOI: 10.1016/J.Schres.2013.04.027 |
0.385 |
|
| 2013 |
Wölwer W, Toeller V, Klingberg S, Gaebel W. Specialised treatment in first episode schizophrenia: Concepts and results | Spezialisierte Behandlungsangebote für erstmals schizophren Erkrankte: Konzepte und Ergebnisse Fortschritte Der Neurologie Psychiatrie. 81: 276-283. PMID 23695792 DOI: 10.1055/S-0032-1330507 |
0.38 |
|
| 2013 |
Gaebel W, Zielasek J, Cleveland HR. Psychotic disorders in ICD-11. Asian Journal of Psychiatry. 6: 263-5. PMID 23642991 DOI: 10.1016/J.Ajp.2013.04.002 |
0.385 |
|
| 2013 |
Anderson-Schmidt H, Adler L, Aly C, Anghelescu IG, Bauer M, Baumgärtner J, Becker J, Bianco R, Becker T, Bitter C, Bönsch D, Buckow K, Budde M, Bührig M, Deckert J, ... ... Gaebel W, et al. The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients. European Archives of Psychiatry and Clinical Neuroscience. 263: 695-701. PMID 23545941 DOI: 10.1007/S00406-013-0401-8 |
0.315 |
|
| 2013 |
Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, ... Gaebel W, et al. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research. 147: 132-9. PMID 23537477 DOI: 10.1016/J.Schres.2013.03.001 |
0.41 |
|
| 2013 |
Großimlinghaus I, Falkai P, Gaebel W, Janssen B, Reich-Erkelenz D, Wobrock T, Zielasek J. Developmental process of DGPPN quality indicators | Entwicklungsprozess der DGPPN-Qualitätsindikatoren Nervenarzt. 84: 350-365. PMID 23494246 DOI: 10.1007/S00115-012-3705-4 |
0.308 |
|
| 2013 |
Musil R, Zill P, Seemüller F, Bondy B, Meyer S, Spellmann I, Bender W, Adli M, Heuser I, Fisher R, Gaebel W, Maier W, Rietschel M, Rujescu D, Schennach R, et al. Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 663-74. PMID 23063133 DOI: 10.1016/J.Euroneuro.2012.08.009 |
0.326 |
|
| 2013 |
Gaebel W. 2474 – Presentation on con European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)77223-7 |
0.364 |
|
| 2013 |
Gaebel W. 2473 – EPA guidance papers and their impact in reducing the burden of mental disorders European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)77222-5 |
0.351 |
|
| 2012 |
Gaebel W, Zielasek J, Cleveland HR. Classifying psychosis--challenges and opportunities. International Review of Psychiatry (Abingdon, England). 24: 538-48. PMID 23244609 DOI: 10.3109/09540261.2012.737313 |
0.405 |
|
| 2012 |
Gaebel W, Zielasek J. Psychiatry in Germany 2012. International Review of Psychiatry (Abingdon, England). 24: 371-8. PMID 22950779 DOI: 10.3109/09540261.2012.698983 |
0.319 |
|
| 2012 |
Bhugra D, Gaebel W, Zielasek J. State of psychiatry in Europe. International Review of Psychiatry (Abingdon, England). 24: 273. PMID 22950763 DOI: 10.3109/09540261.2012.697266 |
0.311 |
|
| 2012 |
Gaebel W, Kowitz S, Zielasek J. The DGPPN research project on mental healthcare utilization in Germany: inpatient and outpatient treatment of persons with depression by different disciplines. European Archives of Psychiatry and Clinical Neuroscience. 262: S51-5. PMID 22940745 DOI: 10.1007/S00406-012-0363-2 |
0.347 |
|
| 2012 |
Seemüller F, Schennach R, Mayr A, Musil R, Jäger M, Maier W, Klingenberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Ohmann C, Lewitzka U, ... Gaebel W, et al. Akathisia and suicidal ideation in first-episode schizophrenia. Journal of Clinical Psychopharmacology. 32: 694-8. PMID 22926606 DOI: 10.1097/Jcp.0B013E3182677958 |
0.362 |
|
| 2012 |
Wölwer W, Stroth S, Brinkmeyer J, Gaebel W. Electrophysiological correlates of planning and monitoring in first episode schizophrenia. Psychiatry Research. 203: 83-8. PMID 22901626 DOI: 10.1016/J.Pscychresns.2011.11.009 |
0.335 |
|
| 2012 |
Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Psychopathology. 45: 276-85. PMID 22796716 DOI: 10.1159/000336729 |
0.401 |
|
| 2012 |
Weinmann S, Gühne U, Kösters M, Gaebel W, Becker T. ManagementTeam-based community psychiatry. Importance of context factors and transferability of evidence from studies | Teambasierte gemeindepsychiatrie: Bedeutung von kontextfaktoren und Übertragbarkeit der studienevidenz Nervenarzt. 83: 825-831. PMID 22688090 DOI: 10.1007/S00115-011-3468-3 |
0.311 |
|
| 2012 |
Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Response trajectories in "real-world" naturalistically treated schizophrenia patients. Schizophrenia Research. 139: 218-24. PMID 22658528 DOI: 10.1016/J.Schres.2012.05.004 |
0.376 |
|
| 2012 |
Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder European Psychiatry. 27: 625-633. PMID 22542652 DOI: 10.1016/J.Eurpsy.2012.01.001 |
0.42 |
|
| 2012 |
Spellmann I, Riedel M, Schennach R, Seemüller F, Obermeier M, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, et al. One-year functional outcomes of naturalistically treated patients with schizophrenia. Psychiatry Research. 198: 378-85. PMID 22421065 DOI: 10.1016/J.Psychres.2011.12.047 |
0.363 |
|
| 2012 |
Gaebel W, Becker T, Janssen B, Munk-Jorgensen P, Musalek M, Rössler W, Sommerlad K, Tansella M, Thornicroft G, Zielasek J. EPA guidance on the quality of mental health services European Psychiatry. 27: 87-113. PMID 22264656 DOI: 10.1016/S0924-9338(11)73901-3 |
0.304 |
|
| 2012 |
Schennach R, Obermeier M, Meyer S, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatric Services (Washington, D.C.). 63: 87-90. PMID 22227766 DOI: 10.1176/Appi.Ps.201100084 |
0.356 |
|
| 2012 |
Gaebel W, Riesbeck M. Only 10% of people with schizophrenia show sustained improvements over 3 years. Evidence-Based Mental Health. 15: 15. PMID 22184639 DOI: 10.1136/Ebmental-2011-100330 |
0.37 |
|
| 2012 |
Gaebel W, Möller HJ. European guidance-a project of the European Psychiatric Association European Psychiatry. 27: 65-67. PMID 22137774 DOI: 10.1016/J.Eurpsy.2011.08.003 |
0.33 |
|
| 2012 |
Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, Brockhaus-Dumke A, Berning J, Janssen B, Decker P, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, et al. Preventing progression to first-episode psychosis in early initial prodromal states. The British Journal of Psychiatry : the Journal of Mental Science. 200: 22-9. PMID 22075649 DOI: 10.1192/Bjp.Bp.109.066357 |
0.363 |
|
| 2012 |
Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial. The Psychiatric Quarterly. 83: 187-207. PMID 22038270 DOI: 10.1007/S11126-011-9193-Z |
0.373 |
|
| 2012 |
Jantzen SU, Ferrea S, Langebner T, Gaebel W, Griese M, Arendt G, Dihné M. Late-stage neurosyphilis presenting with severe neuropsychiatric deficits: diagnosis, therapy, and course of three patients. Journal of Neurology. 259: 720-8. PMID 21964751 DOI: 10.1007/S00415-011-6252-1 |
0.304 |
|
| 2012 |
Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, et al. A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. European Archives of Psychiatry and Clinical Neuroscience. 262: 117-24. PMID 21901269 DOI: 10.1007/S00406-011-0233-3 |
0.353 |
|
| 2012 |
Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 30-8. PMID 21568628 DOI: 10.3109/15622975.2011.552633 |
0.392 |
|
| 2012 |
Wölwer W, Brinkmeyer J, Stroth S, Streit M, Bechdolf A, Ruhrmann S, Wagner M, Gaebel W. Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia. Schizophrenia Bulletin. 38: 1021-9. PMID 21402721 DOI: 10.1093/Schbul/Sbr013 |
0.363 |
|
| 2012 |
Gaebel W, Zielasek J. Essentials of schizophrenia Acta Psychiatrica Scandinavica. 125: 257-257. DOI: 10.1111/J.1600-0447.2011.01819.X |
0.374 |
|
| 2012 |
Gaebel W. W04-04 - Should psychosocial functioning be part of the ICD-11 diagnostic criteria for schizophrenia? European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)75681-X |
0.407 |
|
| 2012 |
Gaebel W, Krupchanka D, Lapushinskaya E. P-868 - Stigmatization of psychiatrists in Belarus European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)75035-6 |
0.323 |
|
| 2012 |
Gaebel W. AS13-04 - Classification of psychotic disorders in ICD-11 European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)73991-3 |
0.36 |
|
| 2012 |
Zarafonitis S, Wagner M, Pützfeld V, Berning J, Janssen B, Decker P, Bottlender R, Möller HJ, Gaebel W, Maier W, Klosterkötter J, Bechdolf A. Psychoeducation for persons at risk of psychosis: Results of a randomized controlled study | Psychoedukation bei Personen mit erhöhtem Psychoserisiko: Ergebnisse einer randomisierten, kontrollierten Studie Psychotherapeut. 57: 326-334. DOI: 10.1007/S00278-012-0928-6 |
0.328 |
|
| 2011 |
Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: a selective review and comparison. International Review of Psychiatry (Abingdon, England). 23: 379-87. PMID 22026495 DOI: 10.3109/09540261.2011.606801 |
0.345 |
|
| 2011 |
Gaebel W, Zäske H, Cleveland HR, Zielasek J, Stuart H, Arboleda-Florez J, Akiyama T, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A, Sartorius N. Measuring the stigma of psychiatry and psychiatrists: development of a questionnaire. European Archives of Psychiatry and Clinical Neuroscience. 261: S119-23. PMID 21947511 DOI: 10.1007/S00406-011-0252-0 |
0.329 |
|
| 2011 |
Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder. Journal of Psychiatric Research. 45: 1639-47. PMID 21862035 DOI: 10.1016/J.Jpsychires.2011.07.014 |
0.409 |
|
| 2011 |
Gaebel W, Zielasek J. Integrative etiopathogenetic models of psychotic disorders: methods, evidence and concepts. Schizophrenia Bulletin. 37: S5-12. PMID 21860047 DOI: 10.1093/Schbul/Sbr078 |
0.338 |
|
| 2011 |
Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, et al. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophrenia Bulletin. 37: S111-21. PMID 21860040 DOI: 10.1093/schbul/sbr083 |
0.337 |
|
| 2011 |
Janssen B, van Brederode M, Kitzig F, Schmidt-Kraepelin C, Ohm S, Gaebel W. [Benchmarking in psychiatric acute care--a demonstration project in a hospitals network]. Zeitschrift FüR Evidenz, Fortbildung Und QualitäT Im Gesundheitswesen. 105: 371-5. PMID 21767796 DOI: 10.1016/J.Zefq.2011.05.016 |
0.322 |
|
| 2011 |
Puschner B, Steffen S, Völker KA, Spitzer C, Gaebel W, Janssen B, Klein HE, Spiessl H, Steinert T, Grempler J, Muche R, Becker T. Needs-oriented discharge planning for high utilisers of psychiatric services: Multicentre randomised controlled trial Epidemiology and Psychiatric Sciences. 20: 181-192. PMID 21714365 DOI: 10.1017/S2045796011000278 |
0.333 |
|
| 2011 |
Gaebel W, Riesbeck M. Evidence-based treatment guidelines for the early illness phase in schizophrenia. Early Intervention in Psychiatry. 2: 303-6. PMID 21352164 DOI: 10.1111/J.1751-7893.2008.00092.X |
0.386 |
|
| 2011 |
Schennach-Wolff R, Jäger M, Mayr A, Meyer S, Kühn KU, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Gaebel W, Seemüller F, Möller HJ, et al. Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 370-8. PMID 21255982 DOI: 10.1016/J.Euroneuro.2010.10.003 |
0.352 |
|
| 2011 |
Lennertz L, Rujescu D, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Landsberg MW, Franke P, Möller HJ, Wölwer W, Gaebel W, Häfner H, Maier W, Mössner R. Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology. 63: 131-6. PMID 21228604 DOI: 10.1159/000317844 |
0.378 |
|
| 2011 |
Umehara H, Fangerau H, Gaebel W, Kim Y, Schott H, Zielasek J. From "schizophrenia" to "disturbance of the integrity of the self". Causes and consequences of renaming schizophrenia in Japan in 2002 | Von der "schizophrenie" zur "störung der einheit des selbst": Ursachen und folgen der umbenennung der schizophrenie in Japan im jahre 2002 Nervenarzt. 82: 1160-1168. PMID 21206996 DOI: 10.1007/S00115-010-3208-0 |
0.412 |
|
| 2011 |
Seitz RJ, Gaebel W, Zielasek J. Modular networks involving the medial frontal cortex: towards the development of neuropsychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 249-59. PMID 21155633 DOI: 10.3109/15622975.2010.541284 |
0.509 |
|
| 2011 |
Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale Acta Psychiatrica Scandinavica. 123: 228-238. PMID 21029053 DOI: 10.1111/J.1600-0447.2010.01608.X |
0.388 |
|
| 2011 |
Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Riedel M, et al. Relationship between baseline severity of depression and antidepressant treatment outcome. Pharmacopsychiatry. 44: 27-32. PMID 20981642 DOI: 10.1055/S-0030-1267177 |
0.302 |
|
| 2011 |
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Lemke M, Heuser I, Maier W, Huff W, Schmitt A, Sauer H, Riedel M, Klingberg S, Köpcke W, et al. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia. The Journal of Clinical Psychiatry. 72: 205-18. PMID 20673559 DOI: 10.4088/Jcp.09M05459Yel |
0.402 |
|
| 2011 |
Schennach-Wolff R, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, et al. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders European Psychiatry. 26: 284-292. PMID 20435447 DOI: 10.1016/J.Eurpsy.2009.11.005 |
0.331 |
|
| 2011 |
Frommann I, Pukrop R, Brinkmeyer J, Bechdolf A, Ruhrmann S, Berning J, Decker P, Riedel M, Möller HJ, Wölwer W, Gaebel W, Klosterkötter J, Maier W, Wagner M. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophrenia Bulletin. 37: 861-73. PMID 20053865 DOI: 10.1093/Schbul/Sbp155 |
0.344 |
|
| 2011 |
Uçok A, Gaebel W. Side effects of atypical antipsychotics: a brief overview. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 58-62. PMID 18458771 DOI: 10.1002/J.2051-5545.2008.Tb00154.X |
0.3 |
|
| 2011 |
Stroth S, Brinkmeyer J, Gaebel W, Wölwer W. Planning and monitoring in Schizophrenia: an eye-movement study International Clinical Psychopharmacology. 26. DOI: 10.1097/01.Yic.0000405926.79522.8C |
0.306 |
|
| 2011 |
Gaebel W, Schreiner A, Bergmans P, Arce RD, Rouillon F, Cordes J, Eriksson L, Smeraldi E. Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111) Neuropsychopharmacology. 36. DOI: 10.1038/Npp.2010.206 |
0.358 |
|
| 2011 |
Gaebel W. Schizophrenia treatment guidelines - an international perspective European Psychiatry. 26: 2187-2187. DOI: 10.1016/S0924-9338(11)73890-1 |
0.388 |
|
| 2011 |
Gaebel W. DB01-01 - Is EBM killing the art of treatment in psychiatry? European Psychiatry. 26: 1790-1790. DOI: 10.1016/S0924-9338(11)73494-0 |
0.318 |
|
| 2011 |
Janssen B, Schmidt-Kraepelin C, Gaebel W. Complex intervention in schizophrenia. Results of an integrated care project in German psychiatry and psychotherapy European Psychiatry. 26: 1408-1408. DOI: 10.1016/S0924-9338(11)73113-3 |
0.373 |
|
| 2010 |
Sartorius N, Gaebel W, Cleveland HR, Stuart H, Akiyama T, Arboleda-Flórez J, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A. WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 9: 131-44. PMID 20975855 DOI: 10.1002/J.2051-5545.2010.Tb00296.X |
0.307 |
|
| 2010 |
Schennach-Wolff R, Möller HJ, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials Pharmacopsychiatry. 43: 245-251. PMID 20927697 DOI: 10.1055/S-0030-1262788 |
0.395 |
|
| 2010 |
Seemüller F, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Schennach-Wolff R, Henkel V, et al. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. The Journal of Clinical Psychiatry. 71: 1425-33. PMID 20816028 DOI: 10.4088/Jcp.09M05166Blu |
0.3 |
|
| 2010 |
Gaebel W, Schreiner A, Bergmans P, de Arce R, Rouillon F, Cordes J, Eriksson L, Smeraldi E. Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2367-77. PMID 20686456 DOI: 10.1038/Npp.2010.111 |
0.4 |
|
| 2010 |
Zielasek J, Freyberger HJ, Jänner M, Kapfhammer HP, Sartorius N, Stieglitz RD, Gaebel W. Assessing the opinions and experiences of German-speaking psychiatrists regarding necessary changes for the 11th revision of the mental disorders chapter of the international classification of disorders (ICD-11) European Psychiatry. 25: 437-442. PMID 20646914 DOI: 10.1016/J.Eurpsy.2009.12.023 |
0.327 |
|
| 2010 |
Schennach-Wolff R, Seemüller FH, Mayr A, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Häfner H, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Riedel M. An early improvement threshold to predict response and remission in first-episode schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 196: 460-6. PMID 20513856 DOI: 10.1192/Bjp.Bp.109.069328 |
0.404 |
|
| 2010 |
Bermejo I, Kriston L, Schneider F, Gaebel W, Hegerl U, Berger M, Härter M. Sick leave and depression - determining factors and clinical effect in outpatient care. Psychiatry Research. 180: 68-73. PMID 20494453 DOI: 10.1016/J.Psychres.2010.04.028 |
0.337 |
|
| 2010 |
Riedel M, Möller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, Kronmüller K, Nickel T, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Seemüller F. Response and remission criteria in major depression--a validation of current practice. Journal of Psychiatric Research. 44: 1063-8. PMID 20447651 DOI: 10.1016/J.Jpsychires.2010.03.006 |
0.315 |
|
| 2010 |
Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, et al. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 729-38. PMID 20380620 DOI: 10.3109/15622971003690289 |
0.375 |
|
| 2010 |
Cordes J, Thünker J, Agelink MW, Arends M, Mobascher A, Wobrock T, Schneider-Axmann T, Brinkmeyer J, Mittrach M, Regenbrecht G, Wölwer W, Winterer G, Gaebel W. Effects of 10 Hz repetitive transcranial magnetic stimulation (rTMS) on clinical global impression in chronic schizophrenia. Psychiatry Research. 177: 32-6. PMID 20378181 DOI: 10.1016/J.Psychres.2009.01.014 |
0.349 |
|
| 2010 |
Lennertz L, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Kühn KU, Pukrop R, Klosterkötter J, Wölwer W, Gaebel W, Rietschel M, Häfner H, Maier W, Mössner R. A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 414-20. PMID 20356718 DOI: 10.1016/J.Euroneuro.2010.02.012 |
0.331 |
|
| 2010 |
von Wilmsdorff M, Sprick U, Bouvier ML, Schulz D, Schmitt A, Gaebel W. Sex-dependent behavioral effects and morphological changes in the hippocampus after prenatal invasive interventions in rats: implications for animal models of schizophrenia. Clinics (Sã£O Paulo, Brazil). 65: 209-19. PMID 20186306 DOI: 10.1590/S1807-59322010000200014 |
0.352 |
|
| 2010 |
Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, Seemüller F, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, et al. Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients Schizophrenia Research. 118: 183-188. PMID 20181461 DOI: 10.1016/J.Schres.2010.02.002 |
0.397 |
|
| 2010 |
Gaebel W, Zielasek J, Cleveland HR. Psychiatry as a medical specialty: challenges and opportunities. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 9: 36-8. PMID 20148157 DOI: 10.1002/J.2051-5545.2010.Tb00265.X |
0.353 |
|
| 2010 |
Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Dichgans E, Bottländer R, et al. Outcomes of 1014 naturalistically treated inpatients with major depressive episode. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 346-55. PMID 20097046 DOI: 10.1016/J.Euroneuro.2009.11.011 |
0.325 |
|
| 2010 |
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Outcome of suicidal patients with schizophrenia: Results from a naturalistic study Acta Psychiatrica Scandinavica. 121: 359-370. PMID 19878135 DOI: 10.1111/J.1600-0447.2009.01484.X |
0.405 |
|
| 2010 |
Janssen B, Ludwig S, Eustermann H, Menke R, Haerter M, Berger M, Adam G, Seemann U, Kissling W, Gaebel W. Improving outpatient treatment in schizophrenia: Effects of computerized guideline implementation-results of a multicenter-study within the German Research Network on Schizophrenia European Archives of Psychiatry and Clinical Neuroscience. 260: 51-57. PMID 19876665 DOI: 10.1007/S00406-009-0016-2 |
0.386 |
|
| 2010 |
Simons G, Ellgring JH, Beck-Dossler K, Gaebel W, Wölwer W. Facial expression in male and female schizophrenia patients. European Archives of Psychiatry and Clinical Neuroscience. 260: 267-76. PMID 19816738 DOI: 10.1007/S00406-009-0074-5 |
0.322 |
|
| 2010 |
Gaebel W. What makes good guidelines? Annals of General Psychiatry. 9. DOI: 10.1186/1744-859X-9-S1-S52 |
0.324 |
|
| 2010 |
Gaebel W. European Treatment Guidelines for schizophrenia Annals of General Psychiatry. 9. DOI: 10.1186/1744-859X-9-S1-S42 |
0.384 |
|
| 2010 |
Schennach-Wolff R, Seemüller F, Mayr A, Maier W, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Häfner H, Sauer H, Schneider F, Gaebel W, Moeller H, Riedel M. S35-01 - Clinical influencing factors of acute treatment outcome in first-episode schizophrenia patients European Psychiatry. 25: 65. DOI: 10.1016/S0924-9338(10)70065-1 |
0.423 |
|
| 2010 |
Gaebel W, Wölwer W, Riesbeck M, Zielasek J. The cross-sectional and longitudinal architecture of schizophrenia: Significance for diagnosis and intervention? Advances in Schizophrenia Research 2009. 317-330. DOI: 10.1007/978-1-4419-0913-8_17 |
0.305 |
|
| 2009 |
Wobrock T, Weinmann S, Falkai P, Gaebel W. Quality assurance in psychiatry: Quality indicators and guideline implementation European Archives of Psychiatry and Clinical Neuroscience. 259: S219-S226. PMID 19876682 DOI: 10.1007/S00406-009-0072-7 |
0.307 |
|
| 2009 |
Gaebel W, Zielasek J. Future classification of psychotic disorders. European Archives of Psychiatry and Clinical Neuroscience. 259: S213-8. PMID 19876681 DOI: 10.1007/S00406-009-0049-6 |
0.337 |
|
| 2009 |
Schmidt-Kraepelin C, Janssen B, Gaebel W. Prevention of rehospitalization in schizophrenia: results of an integrated care project in Germany. European Archives of Psychiatry and Clinical Neuroscience. 259: S205-12. PMID 19876680 DOI: 10.1007/S00406-009-0056-7 |
0.35 |
|
| 2009 |
Kuhn J, Gaebel W, Klosterkoetter J, Woopen C. Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. European Archives of Psychiatry and Clinical Neuroscience. 259: S135-41. PMID 19876671 DOI: 10.1007/S00406-009-0055-8 |
0.35 |
|
| 2009 |
Gaebel W, Janssen B, Zielasek J. Mental health quality, outcome measurement, and improvement in Germany Current Opinion in Psychiatry. 22: 636-642. PMID 19730374 DOI: 10.1097/Yco.0B013E3283317C00 |
0.307 |
|
| 2009 |
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Rüther E, et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophrenia Research. 113: 210-7. PMID 19560901 DOI: 10.1016/J.Schres.2009.05.032 |
0.384 |
|
| 2009 |
Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, G. Schmidt L, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Degner D, Buchkremer G, Gastpar M, Möller HJ, et al. Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study European Psychiatry. 24: 501-506. PMID 19559572 DOI: 10.1016/J.Eurpsy.2009.02.005 |
0.354 |
|
| 2009 |
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Attitude towards adherence in patients with schizophrenia at discharge Journal of Psychiatric Research. 43: 1294-1301. PMID 19505697 DOI: 10.1016/J.Jpsychires.2009.05.003 |
0.36 |
|
| 2009 |
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... Gaebel W, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/Appi.Ajp.2008.08060806 |
0.388 |
|
| 2009 |
Cordes J, Larisch R, Henning U, Thünker J, Werner C, Orozco G, Mayoral F, Rivas F, Auburger G, Tosch M, Rietschel M, Gaebel W, Müller HW, Klimke A. Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis. Depression and Anxiety. 26: E111-9. PMID 19288582 DOI: 10.1002/Da.20405 |
0.322 |
|
| 2009 |
Wobrock T, Gruber O, Schneider-Axmann T, Wölwer W, Gaebel W, Riesbeck M, Maier W, Klosterkötter J, Schneider F, Buchkremer G, Möller HJ, Schmitt A, Bender S, Schlösser R, Falkai P. Internal capsule size associated with outcome in first-episode schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 259: 278-83. PMID 19224108 DOI: 10.1007/S00406-008-0867-Y |
0.376 |
|
| 2009 |
Reske M, Habel U, Kellermann T, Backes V, Jon Shah N, von Wilmsdorff M, Gaebel W, Zilles K, Schneider F. Differential brain activation during facial emotion discrimination in first-episode schizophrenia. Journal of Psychiatric Research. 43: 592-9. PMID 19056093 DOI: 10.1016/J.Jpsychires.2008.10.012 |
0.342 |
|
| 2009 |
Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Journal of Affective Disorders. 115: 439-49. PMID 19027961 DOI: 10.1016/J.Jad.2008.10.011 |
0.32 |
|
| 2009 |
Bermejo I, Schneider F, Kriston L, Gaebel W, Hegerl U, Berger M, Härter M. Improving outpatient care of depression by implementing practice guidelines: a controlled clinical trial. International Journal For Quality in Health Care. 21: 29-36. PMID 18988657 DOI: 10.1093/Intqhc/Mzn050 |
0.33 |
|
| 2009 |
Zielasek J, Gaebel W. Modern modularity and the road towards a modular psychiatry. European Archives of Psychiatry and Clinical Neuroscience. 60-5. PMID 18985297 DOI: 10.1007/S00406-008-5015-1 |
0.3 |
|
| 2009 |
Wölwer W, Brinkmeyer J, Riesbeck M, Freimüller L, Klimke A, Wagner M, Möller HJ, Klingberg S, Gaebel W. Neuropsychological impairments predict the clinical course in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 28-34. PMID 18985291 DOI: 10.1007/S00406-008-5006-2 |
0.387 |
|
| 2009 |
Kircher T, Thienel R, Wagner M, Reske M, Habel U, Kellermann T, Frommann I, Schwab S, Wölwer W, von Wilmsdorf M, Braus DF, Schmitt A, Rapp A, Stöcker T, Shah NJ, ... ... Gaebel W, et al. Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. European Archives of Psychiatry and Clinical Neuroscience. 259: 72-9. PMID 18806920 DOI: 10.1007/S00406-008-0837-4 |
0.347 |
|
| 2009 |
Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Mundt C, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Jäger M, Henkel V, et al. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 181-9. PMID 18662490 DOI: 10.1017/S1461145708009139 |
0.312 |
|
| 2009 |
Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, et al. Prediction of symptom remission in schizophrenia during inpatient treatment. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 426-34. PMID 17853260 DOI: 10.1080/15622970701541054 |
0.4 |
|
| 2009 |
Gaebel W, Bergmans P, de Arce R, Rouillon F, Cordes J, Eriksson L, Schreiner A, Smeraldi E. P03-21 Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable versus quetiapine: Randomized, long-term, open-label, clinical trial results (ConstaTRE) European Psychiatry. 24: S1020. DOI: 10.1016/S0924-9338(09)71253-2 |
0.368 |
|
| 2009 |
Gaebel W. S55-02 How to develop and implement recommended guidance for European psychiatry? European Psychiatry. 24: S268. DOI: 10.1016/S0924-9338(09)70501-2 |
0.311 |
|
| 2009 |
Gaebel W. S43-02 The perspective of German-speaking countries for the future work to develop ICD-11 European Psychiatry. 24: S229. DOI: 10.1016/S0924-9338(09)70462-6 |
0.338 |
|
| 2009 |
Diefenbacher A, Georgescu D, Gaebel W. S40-03 Guidelines in consultation-liaison-psychiatry: A critical comment (TRAC-NR. 1824 5-17-2008) European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70449-3 |
0.332 |
|
| 2008 |
Ebner F, Tepest R, Dani I, Pfeiffer U, Schulze TG, Rietschel M, Maier W, Träber F, Block W, Schild HH, Wagner M, Steinmetz H, Gaebel W, Honer WG, Schneider-Axmann T, et al. The hippocampus in families with schizophrenia in relation to obstetric complications Schizophrenia Research. 104: 71-78. PMID 18656329 DOI: 10.1016/J.Schres.2008.06.007 |
0.35 |
|
| 2008 |
Weinmann S, Hoerger S, Erath M, Kilian R, Gaebel W, Becker T. Implementation of a schizophrenia practice guideline: clinical results. The Journal of Clinical Psychiatry. 69: 1299-306. PMID 18642975 DOI: 10.4088/Jcp.V69N0815 |
0.348 |
|
| 2008 |
Mössner R, Schuhmacher A, Schulze-Rauschenbach S, Kühn KU, Rujescu D, Rietschel M, Zobel A, Franke P, Wölwer W, Gaebel W, Häfner H, Wagner M, Maier W. Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 768-72. PMID 18614340 DOI: 10.1016/J.Euroneuro.2008.05.007 |
0.375 |
|
| 2008 |
Gaebel W, Zielasek J. The DSM-V initiative "deconstructing psychosis" in the context of Kraepelin's concept on nosology. European Archives of Psychiatry and Clinical Neuroscience. 41-7. PMID 18516517 DOI: 10.1007/S00406-008-2009-Y |
0.324 |
|
| 2008 |
Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, ... Gaebel W, et al. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 985-97. PMID 18466670 DOI: 10.1017/S1461145708008791 |
0.392 |
|
| 2008 |
Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 371: 1085-97. PMID 18374841 DOI: 10.1016/S0140-6736(08)60486-9 |
0.391 |
|
| 2008 |
Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin. 34: 1211-20. PMID 18184635 DOI: 10.1093/Schbul/Sbm145 |
0.339 |
|
| 2008 |
Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ, Maier W, Klosterkötter J. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. The British Journal of Psychiatry. Supplement. 51: s88-95. PMID 18055944 DOI: 10.1192/Bjp.191.51.S88 |
0.337 |
|
| 2008 |
Gaebel W, Zäske H, Baumann AE, Klosterkötter J, Maier W, Decker P, Möller HJ. Evaluation of the German WPA "program against stigma and discrimination because of schizophrenia--Open the Doors": results from representative telephone surveys before and after three years of antistigma interventions. Schizophrenia Research. 98: 184-93. PMID 17961985 DOI: 10.1016/J.Schres.2007.09.013 |
0.353 |
|
| 2008 |
Zielasek J, Gaebel W. Modularity in philosophy, the neurosciences, and psychiatry Poiesis & Praxis. 6: 93-108. DOI: 10.1007/S10202-008-0065-Z |
0.341 |
|
| 2007 |
Gaebel W, Riesbeck M. Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia. Schizophrenia Research. 95: 19-29. PMID 17630253 DOI: 10.1016/J.Schres.2007.06.016 |
0.382 |
|
| 2007 |
Allardyce J, Gaebel W, Zielasek J, van Os J. Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophrenia Bulletin. 33: 863-7. PMID 17548844 DOI: 10.1093/Schbul/Sbm051 |
0.4 |
|
| 2007 |
Reske M, Kellermann T, Habel U, Jon Shah N, Backes V, von Wilmsdorff M, Stöcker T, Gaebel W, Schneider F. Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia. Journal of Psychiatric Research. 41: 918-27. PMID 17467008 DOI: 10.1016/J.Jpsychires.2007.02.009 |
0.318 |
|
| 2007 |
Baumann A, Zäske H, Decker P, Klosterkötter J, Maier W, Möller HJ, Gaebel W. [Changes in the public's social distance toward individuals with schizophrenia in six German cities. Results of representative pre- and postinterventional telephone surveys from 2001 to 2004]. Der Nervenarzt. 78: 787-8, 790-5. PMID 17426952 DOI: 10.1007/S00115-006-2172-1 |
0.371 |
|
| 2007 |
Falkai P, Honer WG, Kamer T, Dustert S, Vogeley K, Schneider-Axmann T, Dani I, Wagner M, Rietschel M, Müller DJ, Schulze TG, Gaebel W, Cordes J, Schönell H, Schild HH, et al. Disturbed frontal gyrification within families affected with schizophrenia. Journal of Psychiatric Research. 41: 805-13. PMID 17070846 DOI: 10.1016/J.Jpsychires.2006.07.018 |
0.345 |
|
| 2007 |
Jäger M, Riedel M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, et al. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. European Archives of Psychiatry and Clinical Neuroscience. 257: 47-53. PMID 17033915 DOI: 10.1007/S00406-006-0683-1 |
0.351 |
|
| 2007 |
Schneider F, Habel U, Reske M, Kellermann T, Stöcker T, Shah NJ, Zilles K, Braus DF, Schmitt A, Schlösser R, Wagner M, Frommann I, Kircher T, Rapp A, Meisenzahl E, ... ... Gaebel W, et al. Neural correlates of working memory dysfunction in first-episode schizophrenia patients: an fMRI multi-center study. Schizophrenia Research. 89: 198-210. PMID 17010573 DOI: 10.1016/J.Schres.2006.07.021 |
0.339 |
|
| 2007 |
Stamm K, Salize HJ, Härter M, Brand S, Sitta P, Berger M, Gaebel W, Schneider F. [Cost predictors of depressive inpatient episodes in Germany. The health insurer's point of view]. Der Nervenarzt. 78: 665-71. PMID 16821064 DOI: 10.1007/S00115-006-2115-X |
0.314 |
|
| 2007 |
Gaebel W. Coercive treatment and stigma: is there a link? Bmc Psychiatry. 7: 1-1. DOI: 10.1186/1471-244X-7-S1-S2 |
0.356 |
|
| 2007 |
Gaebel W, Riesbeck M. Results of the German Research Network on Schizophrenia (GRNS): Prodorme-based treatment in first-episode schizophrenia European Psychiatry. 22: S76. DOI: 10.1016/J.Eurpsy.2007.01.293 |
0.382 |
|
| 2007 |
Wölwer W, Riesbeck M, Brinkmeyer J, Gaebel W. Vulnerability-stress-coping model: implications for the treatment of first-episode schizophrenia European Psychiatry. 22. DOI: 10.1016/J.Eurpsy.2007.01.274 |
0.357 |
|
| 2006 |
Sprick U, von Wilmsdorff M, Bouvier ML, Schulz D, Gaebel W. Behavioral and hippocampal changes after prenatal invasive interventions with possible relevance to schizophrenia. Behavioural Brain Research. 172: 179-86. PMID 16806517 DOI: 10.1016/J.Bbr.2006.03.014 |
0.325 |
|
| 2006 |
Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacology. 187: 229-36. PMID 16710714 DOI: 10.1007/S00213-006-0413-4 |
0.324 |
|
| 2006 |
Gaebel W, Zäske H, Baumann AE. The relationship between mental illness severity and stigma. Acta Psychiatrica Scandinavica. Supplementum. 41-5. PMID 16445481 DOI: 10.1111/J.1600-0447.2005.00716.X |
0.328 |
|
| 2006 |
Janssen B, Menke R, Pourhassan F, Geßner-Özokyay D, Peters R, Gaebel W. Leitlinienimplementierung auf der Basis eines computergestützten Decision-support-Systems Nervenarzt. 77: 567-575. PMID 15765230 DOI: 10.1007/S00115-005-1898-5 |
0.302 |
|
| 2005 |
Schneider F, Härter M, Brand S, Sitta P, Menke R, Hammer-Filipiak U, Kudling R, Heindl A, Herold K, Frommberger U, Elmer O, Hetzel G, Witt G, Wolfersdorf M, Berger M, ... Gaebel W, et al. Adherence to guidelines for treatment of depression in in-patients. The British Journal of Psychiatry : the Journal of Mental Science. 187: 462-9. PMID 16260823 DOI: 10.1192/Bjp.187.5.462 |
0.306 |
|
| 2005 |
Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS. Schizophrenia practice guidelines: international survey and comparison. The British Journal of Psychiatry : the Journal of Mental Science. 187: 248-55. PMID 16135862 DOI: 10.1192/Bjp.187.3.248 |
0.377 |
|
| 2005 |
Wölwer W, Frommann N, Halfmann S, Piaszek A, Streit M, Gaebel W. Remediation of impairments in facial affect recognition in schizophrenia: Efficacy and specificity of a new training program Schizophrenia Research. 80: 295-303. PMID 16125367 DOI: 10.1016/J.Schres.2005.07.018 |
0.331 |
|
| 2005 |
Weinmann S, Janssen B, Gaebel W. Guideline adherence in medication management of psychotic disorders: An observational multisite hospital study Acta Psychiatrica Scandinavica. 112: 18-25. PMID 15952941 DOI: 10.1111/J.1600-0447.2005.00547.X |
0.362 |
|
| 2005 |
Schneider F, Menke R, Härter M, Salize HJ, Janssen B, Bergmann F, Berger M, Gaebel W. [Are bonus systems applicable to guideline-oriented depression treatment provided by general practitioners and neurologists?]. Der Nervenarzt. 76: 308-14. PMID 15007509 DOI: 10.1007/S00115-004-1689-4 |
0.319 |
|
| 2004 |
Janssen B, Weinmann S, Berger M, Gaebel W. Validation of polypharmacy process measures in inpatient schizophrenia care Schizophrenia Bulletin. 30: 1023-1033. PMID 15954205 DOI: 10.1093/Oxfordjournals.Schbul.A007117 |
0.422 |
|
| 2004 |
Falkai P, Tepest R, Honer WG, Dani I, Ahle G, Pfeiffer U, Vogeley K, Schulze TG, Rietschel M, Cordes J, Schönell H, Gaebel W, Kühn KU, Maier W, Träber F, et al. Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view. Psychiatry Research. 132: 261-71. PMID 15664797 DOI: 10.1016/J.Pscychresns.2004.03.004 |
0.368 |
|
| 2004 |
Falkai P, Tepest R, Schulze TG, Müller DJ, Rietschel M, Maier W, Träber F, Block W, Schild HH, Steinmetz H, Gaebel W, Honer WG, Schneider-Axmann T, Wagner M. Etiopathogenetic mechanisms in long-term course of schizophrenia Pharmacopsychiatry. 37. PMID 15546065 DOI: 10.1055/S-2004-832667 |
0.369 |
|
| 2004 |
Gaebel W, Wölwer W. Facial expressivity in the course of schizophrenia and depression. European Archives of Psychiatry and Clinical Neuroscience. 254: 335-342. PMID 15365710 DOI: 10.1007/S00406-004-0510-5 |
0.387 |
|
| 2004 |
Weinmann S, Janssen B, Gaebel W. Switching antipsychotics in inpatient schizophrenia care: Predictors and outcomes Journal of Clinical Psychiatry. 65: 1099-1105. PMID 15323596 DOI: 10.4088/Jcp.V65N0812 |
0.426 |
|
| 2004 |
Barkow K, Heun R, Ustün TB, Berger M, Bermejo I, Gaebel W, Härter M, Schneider F, Stieglitz RD, Maier W. Identification of somatic and anxiety symptoms which contribute to the detection of depression in primary health care. European Psychiatry : the Journal of the Association of European Psychiatrists. 19: 250-7. PMID 15276656 DOI: 10.1016/J.Eurpsy.2004.04.015 |
0.302 |
|
| 2004 |
Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 254: 129-40. PMID 15146342 DOI: 10.1007/S00406-004-0509-Y |
0.413 |
|
| 2004 |
Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, Maier W, Bottlender R, Möller HJ, Gaebel W, Wölwer W. Early detection and secondary prevention of psychosis: facts and visions. European Archives of Psychiatry and Clinical Neuroscience. 254: 117-28. PMID 15146341 DOI: 10.1007/S00406-004-0508-Z |
0.363 |
|
| 2004 |
Wölwer W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller HJ, Gaebel W. German research network on schizophrenia-bridging the gap between research and care. European Archives of Psychiatry and Clinical Neuroscience. 253: 321-9. PMID 14714122 DOI: 10.1007/S00406-003-0468-8 |
0.331 |
|
| 2004 |
Baumann AE, Zäske H, Decker P, Möller H, Gaebel W. Öffentlichkeitsaufklärung - Entstigmatisierung schizophrener Erkrankungen Psychoneuro. 30: 624-627. DOI: 10.1055/S-2004-837069 |
0.348 |
|
| 2004 |
Riesbeck M, Wilmsdorff Mv, Krohmer R, Wölwer W, Bottlender R, Möller H, Gaebel W. Optimierung der pharmakologischen Langzeitbehandlung ersterkrankter schizophrener Patienten Psychoneuro. 30: 615-619. DOI: 10.1055/S-2004-837067 |
0.334 |
|
| 2004 |
Schneider F, Habel U, Klein M, Kellermann T, Stoecker T, Braus D, Schmitt A, Schlösser R, Smesny S, Wagner M, Frommann I, Kircher T, Rapp A, Meisenzahl E, Ufer S, ... ... Gaebel W, et al. A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients Pharmacopsychiatry. 36. DOI: 10.1055/S-2003-825505 |
0.342 |
|
| 2003 |
Gaebel W, Baumann AE. Interventions to reduce the stigma associated with severe mental illness: experiences from the open the doors program in Germany. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 657-62. PMID 14674047 DOI: 10.1177/070674370304801003 |
0.398 |
|
| 2003 |
Baumann A, Zaeske H, Gaebel W. [The image of people with mental illness in movies: effects on beliefs, attitudes and social distance, considering as example the movie "The white noise"]. Psychiatrische Praxis. 30: 372-8. PMID 14586821 DOI: 10.1055/S-2003-43245 |
0.358 |
|
| 2003 |
Wülwer W, Falkai P, Streit M, Gaebel W. Trait characteristic of impaired visuomotor integration during Trail-Making Test B performance in schizophrenia Neuropsychobiology. 48: 59-67. PMID 14504412 DOI: 10.1159/000072878 |
0.37 |
|
| 2003 |
Gaebel W, Riesbeck M, Janssen B, Schneider F, Held T, Mecklenburg H, Sass H. Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions. European Archives of Psychiatry and Clinical Neuroscience. 253: 175-84. PMID 12910348 DOI: 10.1007/S00406-003-0422-9 |
0.354 |
|
| 2003 |
Wölwer W, Gaebel W. Impaired visuomotor integration in acute schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 4: 124-8. PMID 12872206 DOI: 10.1080/15622970310029906 |
0.404 |
|
| 2003 |
Wölwer W, Gaebel W. Impaired Trail-Making Test-B performance in patients with acute schizophrenia is related to inefficient sequencing of planning and acting. Journal of Psychiatric Research. 36: 407-16. PMID 12393310 DOI: 10.1016/S0022-3956(02)00050-X |
0.374 |
|
| 2002 |
Gaebel W, Baumann A, Witte AM, Zaeske H. Public attitudes towards people with mental illness in six German cities: results of a public survey under special consideration of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 252: 278-87. PMID 12563536 DOI: 10.1007/S00406-002-0393-2 |
0.412 |
|
| 2002 |
Linden M, Godemann F, Gaebel W, Köpke W, Müller P, Müller-Spahn F, Pietzcker A, Tegeler J. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years. Schizophrenia Bulletin. 27: 585-96. PMID 11824485 DOI: 10.1093/Oxfordjournals.Schbul.A006898 |
0.39 |
|
| 2002 |
Gaebel W, Jänner M, Frommann N, Pietzcker A, Köpcke W, Linden M, Müller P, Müller-Spahn F, Tegeler J. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies Schizophrenia Research. 53: 145-159. PMID 11728846 DOI: 10.1016/S0920-9964(01)00182-7 |
0.337 |
|
| 2001 |
Gaebel W. [Strategies of long-term medication in schizophrenia]. Fortschritte Der Neurologie Psychiatrie. 69: 113-119. PMID 11533861 DOI: 10.1055/S-2001-16541 |
0.37 |
|
| 2001 |
Streit M, Ioannides A, Sinnemann T, Wölwer W, Dammers J, Zilles K, Gaebel W. Disturbed facial affect recognition in patients with schizophrenia associated with hypoactivity in distributed brain regions: a magnetoencephalographic study. The American Journal of Psychiatry. 158: 1429-36. PMID 11532727 DOI: 10.1176/Appi.Ajp.158.9.1429 |
0.327 |
|
| 2001 |
Gaebel W, Frommann N. Long-term course in schizophrenia: concepts, methods and research strategies. Acta Psychiatrica Scandinavica. Supplementum. 49-53. PMID 11261640 DOI: 10.1034/J.1600-0447.2000.00009.X |
0.362 |
|
| 2001 |
Wölwer W, Gaebel W. Eye Movement Strategies in Schizophrenia: A Window to Frontal Lobe Dysfunctions? Zeitschrift FüR Neuropsychologie. 12: 21-25. DOI: 10.1024//1016-264X.12.1.21 |
0.336 |
|
| 2000 |
Baumgartner A, Pietzcker A, Gaebel W. The hypothalamic-pituitary-thyroid axis in patients with schizophrenia. Schizophrenia Research. 44: 233-43. PMID 10962225 DOI: 10.1016/S0920-9964(99)00187-5 |
0.343 |
|
| 2000 |
Janssen B, Burgmann C, Habel U, Held T, Hoff P, Jänner M, Mecklenburg H, Prüter C, Ruth A, Sass H, Schneider F, Gaebel W. [External quality assurance of inpatient treatment in schizophrenia. results of a multicenter study]. Der Nervenarzt. 71: 364-72. PMID 10846711 DOI: 10.1007/S001150050570 |
0.338 |
|
| 2000 |
Gaebel W, Jänner M, Frommann N, Pietzcker A, Köpcke W, Linden M, Müller P, Müller-Spahn F, Tegeler J. Prodromal states in schizophrenia. Comprehensive Psychiatry. 41: 76-85. PMID 10746908 DOI: 10.1016/S0010-440X(00)80012-7 |
0.413 |
|
| 2000 |
Gaebel W, Jänner M, Frommann N. S42.01 Prodromal Symptoms in Schizophrenia: State of the Art European Psychiatry. 15: 300s-301s. DOI: 10.1016/S0924-9338(00)94314-1 |
0.355 |
|
| 2000 |
Sartorius N, Lopez-Ibor J, Gaebel W, Schöny W, Rossi G. C06.01 Developing Programmes Against Stigma and Discrimination because of Schizophrenia European Psychiatry. 15: 297s-298s. DOI: 10.1016/S0924-9338(00)94303-7 |
0.356 |
|
| 2000 |
Wölwer W, Streit M, Frommann N, Gaebel W. Facial affect recognition in schizophrenia: State-/trait-characteristic and clinical correlates Schizophrenia Research. 41: 288. DOI: 10.1016/S0920-9964(00)91029-6 |
0.351 |
|
| 1999 |
Burtscheidt W, Schwarz R, Redner C, Gaebel W. Verhaltenstherapeutische Verfahren in der ambulanten Behandlung von Alkoholabhängigen Fortschritte Der Neurologie Psychiatrie. 67: 274-280. PMID 10399047 DOI: 10.1055/S-2007-994976 |
0.307 |
|
| 1998 |
Gaebel W. Critical issues in the treatment of schizophrenia. International Clinical Psychopharmacology. S1-6. PMID 9690963 DOI: 10.1097/00004850-199803003-00001 |
0.409 |
|
| 1998 |
Müller U, Klimke A, Jänner M, Gaebel W. [Electroconvulsive therapy in psychiatric clinics in Germany in 1995]. Der Nervenarzt. 69: 15-26. PMID 9522329 DOI: 10.1007/S001150050234 |
0.337 |
|
| 1998 |
Doering S, Müller E, Köpcke W, Pietzcker A, Gaebel W, Linden M, Müller P, Müller-Spahn F, Tegeler J, Schüssler G. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophrenia Bulletin. 24: 87-98. PMID 9502548 DOI: 10.1093/oxfordjournals.schbul.a033316 |
0.304 |
|
| 1997 |
Streit M, Wölwer W, Gaebel W. Facial-affect recognitionand visual scanning behaviour in the course of schizophrenia Schizophrenia Research. 24: 311-317. PMID 9134591 DOI: 10.1016/S0920-9964(96)00126-0 |
0.312 |
|
| 1997 |
Juckel G, Müller-Schubert A, Gaebel W, Hegerl U. Residual symptoms and P300 in schizophrenic outpatients. Psychiatry Research. 65: 23-32. PMID 8953658 DOI: 10.1016/0165-1781(96)02835-1 |
0.314 |
|
| 1997 |
Gaebel W, Marder S. Conclusions and treatment recommendations for the acute episode in schizophrenia. International Clinical Psychopharmacology. 93-100. PMID 8803667 DOI: 10.1097/00004850-199605002-00015 |
0.361 |
|
| 1997 |
Gaebel W. Prediction of response to acute neuroleptic treatment in schizophrenia. International Clinical Psychopharmacology. 47-54. PMID 8803660 DOI: 10.1097/00004850-199605002-00008 |
0.337 |
|
| 1997 |
Gaebel W. Towards the improvement of compliance International Clinical Psychopharmacology. 12: S37-S42. DOI: 10.1097/00004850-199702001-00006 |
0.355 |
|
| 1997 |
Wölwer W, Streit M, Falkai P, Gaebel W. Dysfunctional visual scanning strategies in schizophrenia: A trait-characteristic? Biological Psychiatry. 42: 185S. DOI: 10.1016/S0006-3223(97)87676-7 |
0.342 |
|
| 1997 |
Streit M, Wölwer W, Ihi R, Brinkmeyer J, Gaebel W. EEG correlates of facial affect recognition and visual object recognition in schizophrenia Biological Psychiatry. 42: 141S. DOI: 10.1016/S0006-3223(97)87478-1 |
0.318 |
|
| 1996 |
Wolwer W, Streit M, Polzer U, Gaebel W. Facial affect recognition in the course of schizophrenia European Archives of Psychiatry and Clinical Neuroscience. 246: 165-170. PMID 8739402 DOI: 10.1007/Bf02189118 |
0.368 |
|
| 1996 |
Wölwer W, Streit M, Gaebel W. Visual scanning strategies and cognitive dysfunctions in a visuomotor tracking task in the course of schizophrenia European Psychiatry. 11: 218s-219s. DOI: 10.1016/0924-9338(96)88641-X |
0.32 |
|
| 1996 |
Wölwer W, Kiesow S, Streit M, Gaebel W. Visuomotor integration and cognitive flexibility in schizophrenia Schizophrenia Research. 18: 218. DOI: 10.1016/0920-9964(96)85673-8 |
0.34 |
|
| 1995 |
Gaebel W. Is intermittent, early intervention medication an alternative for neuroleptic maintenance treatment? International Clinical Psychopharmacology. 11-6. PMID 7622828 DOI: 10.1097/00004850-199501005-00003 |
0.355 |
|
| 1995 |
Klimke A, Boy C, Müller-Gärtner H, Gaebel W. P-3-6 Investigating dopamine receptor binding with PET and SPECT ligands in schizophrenia: Clinical and methodological considerations European Neuropsychopharmacology. 5: 318-319. DOI: 10.1016/0924-977X(95)90496-Z |
0.309 |
|
| 1994 |
Gaebel W. Intermittent medication--an alternative? Acta Psychiatrica Scandinavica. Supplementum. 382: 33-8. PMID 7916527 DOI: 10.1111/J.1600-0447.1994.Tb05863.X |
0.357 |
|
| 1993 |
Polzer U, Juckel G, Gaebel W. Dopaminergic-serotonergic dysfunction in schizophrenia - a new research approach using the assessment of facial activity Schizophrenia Research. 9: 186. DOI: 10.1016/0920-9964(93)90375-S |
0.352 |
|
| 1993 |
Gaebel W, Wölwer W. Goal-directed visuomotor behaviour - dysfunctional interaction of eye- and hand-movements in schizophrenia Schizophrenia Research. 9: 174. DOI: 10.1016/0920-9964(93)90336-H |
0.308 |
|
| 1992 |
Bandelow B, Müller P, Frick U, Gaebel W, Linden M, Müller-Spahn F, Pietzcker A, Tegeler J. Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of Germany. European Archives of Psychiatry and Clinical Neuroscience. 241: 291-5. PMID 1351405 DOI: 10.1007/Bf02195978 |
0.306 |
|
| 1992 |
Gaebel W. Non-verbal Behavioural Dysfunction in Schizophrenia British Journal of Psychiatry. 161: 65-74. DOI: 10.1192/S0007125000297079 |
0.374 |
|
| 1991 |
Gaebel W, Kopcke W, Linden M, Muller P, Muller-Spahn F, Pietzcker A, Tegeler J. 2-year-outcome of intermittent vs. maintenance neuroleptic treatment in schizophrenia Schizophrenia Research. 4: 288-289. DOI: 10.1016/0920-9964(91)90162-K |
0.373 |
|
| 1989 |
Gaebel W. Treatment course, clinical and neurobiological correlates of negative symptoms - towards an integraative model of schizophrenia Schizophrenia Research. 2: 62. DOI: 10.1016/0920-9964(89)90098-4 |
0.385 |
|
| 1987 |
Pietzcker A, Gaebel W. Prospective study of course of illness in schizophrenia: Part I. Outcome at 1 year. Schizophrenia Bulletin. 13: 287-97. PMID 3616520 DOI: 10.1093/Schbul/13.2.287 |
0.378 |
|
| 1987 |
Gaebel W, Pietzcker A. Prospective study of course of illness in schizophrenia: Part III. Treatment and outcome. Schizophrenia Bulletin. 13: 307-16. PMID 2887033 DOI: 10.1093/Schbul/13.2.307 |
0.376 |
|
| 1986 |
Gaebel W, Pietzcker A, Baumgartner A. 3-Year Follow-up of Schizophrenic Patients - Outcome Dimensions and Neuroleptic Treatment Pharmacopsychiatry. 19: 208-209. DOI: 10.1055/S-2007-1017198 |
0.301 |
|
| Show low-probability matches. |